Molecular and Cellular Pharmacology, Vol 6, No 3 (2014)
FDA Approves Weight-management Drug Saxenda
FDA News Release
Abstract
The U.S. Food and Drug Administration today approved Saxenda (liraglutide [rDNA origin] injection) as a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity...….(click PDF to read more)
Full Text: PDF
Our partner: Crossroads Pharmacy 2800 Hwy 101, Rogersville, AL 35652 LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 Copyright © 2008 LumiText Publishing. All rights reserved.